A maintenance study to investigate the efficacy and safety of duvakitug in participants with moderately to severely active Crohn's Disease in adult participants 18 years of age and older who have completed protocol EFC18326 Startscape-1.
Eligibility of study
You may be eligible for this study if you meet the following criteria: